載入...

Transient Potential Receptor Melastatin-2 (TRPM2) Does Not Influence Murine MLL-AF9 Driven AML Leukemogenesis or in Vitro Response to Chemotherapy

Transient potential receptor melastatin-2 (TRPM2) is a non-selective cationic, Ca(2+) permeable transmembrane pore that is preferentially expressed in cells of the myeloid lineage, and modulates signaling pathways converging onto NF-kB. This is of potential interest for AML therapy, as NF-κB signali...

全面介紹

Na minha lista:
書目詳細資料
發表在:Exp Hematol
Main Authors: Haladyna, Jessica N., Pastuer, Taylor, Riedel, Simone S, Perraud, Anne-Laure, Bernt, Kathrin M
格式: Artigo
語言:Inglês
出版: 2016
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4914470/
https://ncbi.nlm.nih.gov/pubmed/27033163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.exphem.2016.03.006
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!